Astellas Pharma Europe, Ltd. Launches Action on Fistula Corporate Giving Campaign

astellas_corporate_giving

On May 23, the United Nations’ International Day to End Obstetric Fistula, Astellas Pharma Europe announced their record $2 million donation to Fistula Foundation to 250 employees at a town hall event at their corporate headquarters in Chertsey, England. Fistula Foundation Board Chair, Dr. Sohier Elneil, attended the meeting and gave remarks about the Action on Fistula campaign and how Astellas’ donation will help women who are suffering from fistula in Kenya. Astellas Pharma Europe President & CEO, Ken Jones, and Vice President of Licensing and Alliances, Naoki Okamura, also spoke during the event.

Furthering their company’s generous commitment, Astellas Pharma Europe employees will also be raising funds for Fistula Foundation in offices throughout Europe via fundraising events and through individual contributions.

“Action on Fistula tackles a significant unmet need for treatment in urology, where we have a strong heritage. Through our flagship corporate giving program with Fistula Foundation we want to help treat more women living with this devastating condition. Critically, the program will build capacity through surgical training so that even more women can be treated in the future,” said Mr. Jones.

View the Action on Fistula campaign website at www.astellas.eu/action-on-fistula.

This article originally appeared in Fistula Foundation’s Summer 2014 newsletter. Click here to view a PDF of the entire newsletter.

Tags: , , ,